Showing results (51-60 of 143) with videos related to
Sort By:
Pageof 15
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|August 8, 2025
Thyroid Arterial Embolization for the Management of Benign and Malignant Thyroid Disease: A Systematic ReviewHannelore Iris Coerts, Brooke D'Mello, Frederik Anton Verburg, et al.Nederlands Tijdschrift Voor Geneeskunde|January 12, 2023
[PSMA PET, an important addition in prostate cancer diagnostics]Esmée C A van der Sar, Jules Lavalaye, Arthur J A T Braat, et al.Plos One|February 14, 2013
Quantitative comparison of PET and Bremsstrahlung SPECT for imaging the in vivo yttrium-90 microsphere distribution after liver radioembolizationMattijs Elschot, Bart J Vermolen, Marnix G E H Lam, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 7, 2004
Bone marrow dosimetry and safety of high 131I activities given after recombinant human thyroid-stimulating hormone to treat metastatic differentiated thyroid cancerBart de Keizer, Anne Hoekstra, Mark W Konijnenberg, et al.Acta Radiologica (Stockholm, Sweden : 1987)|February 15, 2015
Accuracy of whole-body MRI in the assessment of splenic involvement in lymphomaAnnemieke S Littooij, Thomas C Kwee, Ignasi Barber, et al.EJNMMI Research|December 14, 2021
First experiences with <sup>177</sup>Lu-PSMA-617 therapy for recurrent or metastatic salivary gland cancerThomas J W Klein Nulent, Robert J J van Es, Stefan M Willems, et al.Oral Oncology|November 21, 2024
Evaluation of the 10 %-rule in sentinel lymph node biopsy for clinically node-negative oral squamous cell carcinomaRoosmarijn S Tellman, Dominique N V Donders, Rutger Mahieu, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 24, 2021
Intraarterial Administration Boosts <sup>177</sup>Lu-HA-DOTATATE Accumulation in Salvage Meningioma PatientsEvert-Jan P A Vonken, Rutger C G Bruijnen, Tom J Snijders, et al.Future Oncology (London, England)|September 22, 2025
[<sup>18</sup>F]Tetrafluoroborate PET/CT for detecting differentiated thyroid cancer: phase-II study protocolHannelore I Coerts, Tessa M van Ginhoven, W Edward Visser, et al.European Journal of Nuclear Medicine and Molecular Imaging|January 23, 2008
Hormonal crises following receptor radionuclide therapy with the radiolabeled somatostatin analogue [177Lu-DOTA0,Tyr3]octreotateBart de Keizer, Maarten O van Aken, Richard A Feelders, et al.Pageof 15